Scotts Miracle-Gro Highlights Lawn Demand as Growth Strategy Shifts

Core Lawn Business Drives Near-Term Revenue Outlook

Scotts Miracle-Gro is prioritizing its legacy lawn and garden segment as the primary revenue driver for fiscal 2027. The company noted sustained consumer demand for turf fertilizers, weed control, and seasonal outdoor products—categories that generated most of its $3.6 billion in net sales for fiscal 2026. Point-of-sale data from big-box retail partners showed double-digit year-over-year growth in lawn-care SKUs during the spring selling season, according to management.

The lawn segment's performance stands in sharp contrast to Hawthorne, the company's hydroponics and indoor-growing subsidiary. Hawthorne revenue declined 42% from its 2021 peak. Legal cannabis cultivation markets contracted. State-level oversupply hit hard, and wholesale flower prices tumbled.

Hawthorne Stabilization Remains a Multi-Year Project

The Hawthorne unit posted flat sequential revenue in Q3 2026, the first quarter without a year-over-year decline since mid-2022. Management attributed the stabilization to three factors:

• Reduced inventory levels at cannabis cultivators following two years of destocking
• New product launches in LED grow lights and controlled-environment nutrients
• Modest upticks in commercial cultivation capex in mature markets like California and Colorado

Hawthorne's adjusted EBITDA margin improved 320 basis points quarter-over-quarter to 8.4%, though it's still well below the division's 2021 margin peak of 18%. SMG executives said they expect Hawthorne to return to low-single-digit revenue growth by fiscal 2028, contingent on federal cannabis rescheduling and expanded state licensing.

Balance Sheet and Capital Allocation Priorities

Scotts Miracle-Gro reported net debt of $2.1 billion as of June 30, 2026, with a leverage ratio of 3.2x trailing-twelve-month adjusted EBITDA. The company suspended its dividend in Q4 2025 to prioritize debt reduction. Management reiterated a target leverage ratio of 2.5x by the end of fiscal 2027, achievable through free cash flow generation of $400-$450 million annually, working capital optimization (particularly inventory drawdowns at Hawthorne), and selective asset sales including non-core real estate holdings.

CFO comments during the update suggested the company won't resume share buybacks or reinstate the dividend until it hits that 2.5x target. For context on Scotts Miracle-Gro's broader strategic positioning and its Hawthorne unit's evolution, see the CannIntel topic hub on Scotts Miracle-Gro & Hawthorne Gardening.

Investor Sentiment and Forward Guidance

SMG shares closed July 7 at $68.14, up 1.8% on the session but still down 34% from their 2021 high of $103. The stock's underperformance reflects lingering investor caution around Hawthorne's revenue trajectory and the company's elevated debt load. Analysts at KeyBanc maintained a Sector Weight rating, citing "limited near-term catalysts" for multiple expansion absent clearer federal cannabis policy signals.

Management issued fiscal 2027 guidance calling for consolidated revenue growth of 3-5% and adjusted EPS of $5.20-$5.60, implying a return to modest profitability expansion. The guidance assumes no material federal cannabis reform and stable commodity input costs.

Next catalyst? Fiscal Q4 2026 earnings in late August, when SMG will detail full-year Hawthorne performance and update its fiscal 2027 outlook with post-spring-season retail data.